Dgci

Rediff.com » News » Dgci

News for Dgci

News
Business

Govt denies pressuring Covaxin makers for early release of vaccine

The Union health ministry on Thursday termed as 'misleading' and 'fallacious' media reports which claimed that regulatory approval for COVID-19 vaccine Covaxin was rushed due to political pressure.......

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which......

DGCI denies emergency use nod to Sputnik-Light vaccine

India's drug regulator has refused to grant emergency-use authorisation to single-dose COVID-19 vaccine Sputnik-Light, while ruling out the need for the conduct of the phase-3 trial of the Russian......

Serum Institute gets DGCI nod to manufacture Sputnik V in India

The Drugs Controller General of India (DCGI) has granted permission to the Serum Institute of India (SII) to manufacture the Sputnik COVID-19 vaccine in India for examination, test and analysis......

DGCI approves Covaxin for phase 2/3 trials on children

India's apex drug regulator has granted permission for conducting the phase II/III clinical trial of Bharat Biotech's Covaxin COVID-19 vaccine in the age group of 2 to 18 years, the Union Health......

Another Indian COVID-19 vaccine candidate gets nod for human trial

Zydus plans to initiate the clinical trials of ZyCoV-D in July 2020 across multiple sites in India. In animal studies the vaccine was found to elicit a strong immune response in multiple animal......

As supply slumps, onions prices rise by up to 76%

The crop is currently trading at Rs 22 a kg compared to Rs 12.50 one month ago. Photograph: Amit Dave/Reuters Onion prices jumped by up to 76 per cent in the last one month due to reduction in......

FDA asks stent makers to get DGCI approval

Acting swiftly on the controversy regarding illegal drug-coated stents, the Maharashtra Food and Drug Administration has asked all stent manufacturers and importers to get valid licenses within the......

Stringent law on anvil for services data

The government is considering framing legislation for a stringent penalty on companies not providing information or giving false data on trade in services. Unlike in goods, the country does......

Indian drug regulator threatens to ban Ranbaxy

A day after getting a show-cause notice from the Indian regulator, senior executives from Ranbaxy Laboratories approached the drug controller's office on Tuesday afternoon, it was learnt. The......

Rediff News

Dgci

News for Dgci

Govt denies pressuring Covaxin makers for early release of vaccine

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

DGCI denies emergency use nod to Sputnik-Light vaccine

Serum Institute gets DGCI nod to manufacture Sputnik V in India

DGCI approves Covaxin for phase 2/3 trials on children

Another Indian COVID-19 vaccine candidate gets nod for human trial

As supply slumps, onions prices rise by up to 76%

FDA asks stent makers to get DGCI approval

Stringent law on anvil for services data

Indian drug regulator threatens to ban Ranbaxy

Top Coverage News

World Test Championship 2023

Manipur's Tragedy

IPL 2023

Sri Lanka's Tour of India 2023

GUJARAT, HIMACHAL GO TO POLLS